» Articles » PMID: 37056966

Anticancer Therapeutic Potential of Benzofuran Scaffolds

Overview
Journal RSC Adv
Specialty Chemistry
Date 2023 Apr 14
PMID 37056966
Authors
Affiliations
Soon will be listed here.
Abstract

Benzofuran moiety is the main component of many biologically active natural and synthetic heterocycles. These heterocycles have unique therapeutic potentials and are involved in various clinical drugs. The reported results confirmed the extraordinary inhibitory potency of such benzofurans against a panel of human cancer cell lines compared with a wide array of reference anticancer drugs. Several publications about the anticancer potencies of benzofuran-based heterocycles were encountered. The recent developments of anticancer activities of both natural and synthetic benzofuran scaffolds during 2019-2022 are thoroughly covered. Many of the described benzofurans are promising candidates for development as anticancer agents based on their outstanding inhibitory potency against a panel of human cancer cells compared with reference anticancer drugs. These findings encourage medicinal chemists to explore new areas to improve human health and reduce suffering.

Citing Articles

The synthesis and investigation of novel 3-benzoylbenzofurans and pyrazole derivatives for anti-HIV activity.

Khuzwayo S, Selepe M, Meyer D, Gama N RSC Med Chem. 2025; .

PMID: 40060998 PMC: 11883425. DOI: 10.1039/d4md00844h.


Characterization of Volatilized Compounds in Conventional and Organic Vegetable-Source Alternative Meat-Curing Ingredients.

Sheng S, Silva E, Ricke S, Claus J Molecules. 2025; 30(4).

PMID: 40005146 PMC: 11858521. DOI: 10.3390/molecules30040835.


New Benzofuran-Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies.

Abd El-Karim S, Anwar M, Syam Y, Awad H, El-Dein A, El-Ashrey M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770506 PMC: 11676098. DOI: 10.3390/ph17121664.


Synthesis of Benzofuran Derivatives via a DMAP-Mediated Tandem Cyclization Reaction Involving -Hydroxy α-Aminosulfones.

Zhu R, Hou X, Du D Molecules. 2024; 29(16).

PMID: 39202804 PMC: 11357171. DOI: 10.3390/molecules29163725.


Inhibition of Clostridioides difficile toxins TcdA and TcdB by the amiodarone derivative dronedarone.

Matylitsky J, Krieg A, Schumacher J, Borho J, Barth H, Papatheodorou P Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9877-9885.

PMID: 38935126 PMC: 11582217. DOI: 10.1007/s00210-024-03248-8.


References
1.
Abdelhafez O, Ahmed E, Abdel Latif N, Arafa R, Abd Elmageed Z, Ali H . Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds. Bioorg Med Chem. 2019; 27(7):1308-1319. DOI: 10.1016/j.bmc.2019.02.027. View

2.
Sivaraman A, Kim J, Harmalkar D, Min K, Park J, Choi Y . Synthesis and Cytotoxicity Studies of Bioactive Benzofurans from and Modified Synthesis of Ailanthoidol, Homoegonol, and Egonol. J Nat Prod. 2020; 83(11):3354-3362. DOI: 10.1021/acs.jnatprod.0c00697. View

3.
Ma L, Tang L, Yi Q . Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer. Front Pharmacol. 2019; 10:97. PMC: 6391314. DOI: 10.3389/fphar.2019.00097. View

4.
Radadiya A, Shah A . Bioactive benzofuran derivatives: An insight on lead developments, radioligands and advances of the last decade. Eur J Med Chem. 2015; 97:356-76. DOI: 10.1016/j.ejmech.2015.01.021. View

5.
Mokenapelli S, Thalari G, Vadiyaala N, Yerrabelli J, Irlapati V, Gorityala N . Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles. Arch Pharm (Weinheim). 2020; 353(6):e2000006. DOI: 10.1002/ardp.202000006. View